全球心血管药物研发动态

在全球范围内,心血管疾病仍然是死亡的元凶。因此从流行病学角度看,心血管疾病是公共卫生关注的重要领域。文中从心血管疾病的现状、心血管药物市场分析、心血管药物研发现状等方面对全球心血管药物研究的全景进行了详尽分析,分析了当前心血管药物研发领域更具挑战的环境,如重要产品的溃败以及研发面临的困难等,同时也指出尽管研发环境不容乐观,心血管疾病治疗领域仍然是最可获利的市场领域,通过开发独特创新机制药物、采用新技术以及开发新的复方制剂,心血管药物的开发前景仍然十分广阔。另外,还对心血管药物几个重大领域(抗凝剂、抗动脉粥样硬化药物、抗高血压药、抗心力衰竭药、抗心绞痛药、抗心律失常药)的最新研发动态及重要的在研药物进行了综述。

Progress in global research and development of cardiovascular medicines

Globally,cardiovascular disease(CVD) kills more people than any other diseases.Therefore,epidemiological considerations mean that CVD will remain an important area of public health concern in the main pharmaceutical markets.The panorama of the cardiovascular medicines was thoroughly analyzed concerning the status quo,marketing analysis and R&D actuality.Despite of the more challenging environment,several major players seem to consider that the CVD market still includes areas of important unmet need.Meanwhil...